Parker Highlander PLLC
Development of influenza A antivirals
The present invention includes compositions, methods and systems to isolate and characterize novel antiviral agents by contacting the antiviral agent with the F2F3 zinc fingers of a CPSF30 protein and an Influenza A NS1A protein; and determining whether the binding between the CPSF30 protein and the Influenza A NS1A protein is reduced.
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMS
C C A C C C C C C A A C A
C12N C12N A61K C07K C07K C12N C12N C07K C12N A61K A61K C12N A61K
additional additional additional inventional additional additional additional additional additional additional additional additional additional
Robert M. Karen Y.
Krug Twu